Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Ginkgo Bioworks Holdings Inc’s current trading price is -19.29% away from its 52-week high, while its distance from the 52-week low is 172.00%. The stock’s price range during this period has varied between $5.00 and $16.85. The company, active in the Healthcare sector, saw a trading volume of around 1.56 million for the day, considerably higher average daily volume of 1.42 million observed over the last three months.
Ginkgo Bioworks Holdings Inc (DNA) current stock price is $13.6. During the last trading session, the stock soared, reaching $12.0 after opening at $13.6. The stock’s lowest point was $6.0 before it closed at $12.19.
In terms of market performance, Ginkgo Bioworks Holdings Inc had a somewhat regular.
How Financial Performance Impacts Market Capitalization
Ginkgo Bioworks Holdings Inc (DNA) has experienced a quarterly rise of 93.18% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 796.03M and boasts a workforce of 834 employees.
Decoding Analysts’ Ratings for Ginkgo Bioworks Holdings Inc
As of right now, 1 analyst is rating Ginkgo Bioworks Holdings Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 2 of them gave the stock UNDERWEIGHT rating, and 1 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 8.64, with a change in price of +6.66. Similarly, Ginkgo Bioworks Holdings Inc recorded 1,400,006 in trading volume during the last 100 days, posting a change of +95.97%.
How DNA’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for DNA stands at 0.67. Similarly, the long-term debt-to-equity ratio is also 0.67.
DNA Stock Stochastic Average
As of today, the raw stochastic average of Ginkgo Bioworks Holdings Inc over the last 50 days is at 78.71%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 69.73%. Further, the company’s Stochastic %K and %D values for the last 20 days were 59.69% and 58.42%, respectively.
DNA Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Until today this year the stock’s price performance recorded a decrease of -10.53%. However, over the last six months, the performance has been weaker by 1.80%. The price of DNA increased 6.92% over the last 30 days. And in the last five days, it has fallen by -2.58%.
